This document provides guidance on photosafety testing strategies for pharmaceuticals. It applies to new active pharmaceutical ingredients, new excipients clinical formulations for dermal application and photodynamic therapy products.

Keywords: Photosafety, phototoxicity, photoreactivity, photoallergy, non-clinical, clinical

Current effective version

Document history - First version (current)

Superseded documents

Share this page